Lehrstuhl für Strahlentherapie

Pathologic complete response after induction therapy-the role of surgery in stage IIIA/B locally advanced non-small cell lung cancer (2018) Schreiner W, Gavrychenkova S, Dudek W, Rieker R, Lettmaier S, Fietkau R, Sirbu H Journal article Long-Term Survival after Salvage Surgery for Local Failure after Definitive Chemoradiation Therapy for Locally Advanced Non-small Cell Lung Cancer (2018) Schreiner W, Dudek W, Lettmaier S, Fietkau R, Sirbu H Journal article Lung Resection after Definitive and Neo-Adjuvant Chemoradiation for Stage IIIA/B Locally Advanced Non-Small Cell Lung Cancer: a Retrospective Analysis (2018) Schreiner W, Gavrychenkova S, Dudek W, Lettmaier S, Rieker R, Fietkau R, Sirbu H Journal article Whole-Body Electromyostimulation combined with personalized Nutritional Support improves the Body Composition of Patients with advanced Cancer (2018) Schink K, Herrmann HJ, Schwappacher R, Orlemann T, Meyer J, Waldmann E, Wullich B, et al. Conference contribution Effects of whole-body electromyostimulation combined with individualized nutritional support on body composition in patients with advanced cancer: a controlled pilot trial (2018) Schink K, Herrmann HJ, Schwappacher R, Meyer J, Orlemann T, Waldmann E, Wullich B, et al. Journal article Can clinicopathological parameters predict for lymph node metastases in ypT0-2 rectal carcinoma? Results of the CAO/ARO/AIO-94 and CAO/ARO/AIO-04 phase 3 trials (2018) Von Den Gruen JM, Hartmann A, Fietkau R, Ghadimi M, Liersch T, Hohenberger W, Weitz J, et al. Journal article Medication safety in patients treated with new oral antitumor agents: A prospective, randomized investigation on the impact of intensified clinical pharmaceutical/clinical pharmacological care on patient safety, patient knowledge and patient well-being (AMBORA). Supported by the German Cancer Aid within the Comprehensive Cancer Center Erlangen-EMN (2018) Schlichtig K, Lechner P, Grafe C, Ferstl B, Fuchs F, Hein A, Meidenbauer N, et al. Conference contribution Radiation and checkpoint Blockade in the treatment of metastases (2018) Hirschmann E, Gaipl U, Fietkau R, Distel L, Hecht M Conference contribution Predictive character of peripheral blood immunophenotype before and during treatment with PD-1 immune checkpoint inhibitors (interim analysis of the prospective phase IV ST-ICI trial) (2018) Hecht M, Harrer A, Rutzner S, Lettmaier S, Wolf W, Fietkau R, Frey B, Gaipl U Conference contribution Correction to expert consensus on re-irradiation for recurrent glioma (2018) Krauze AV, Attia A, Braunstein S, Chan M, Combs SE, Fietkau R, Fiveash J, et al. Journal article